COLUMBUS, Ohio -With 9 in 10 Americans favoring legalization of Marijuana for recreation or medicinal purposes and New York weeks away from a decision, aging expert Lisa Cini shares details of marijuana and cannabidiol (CBD) usage among the 11,000+ boomers who responded to her marijuana survey and answered a variety of questions on marijuana consumption, opinion, and usage.
“It’s time to mainstream senior-friendly tools for using marijuana,
and consider implications for designing seniors’ living spaces, or help
those marijuana-using seniors living in multi-generational homes to
partake in designated ways and areas as not to offend family members who
don’t use, including children and grandchildren.â€Tweet this
“I’m not surprised that 83% of the respondents are using some form of
cannabis for recreational and medical reasons. 66% partake daily and
believe that marijuana and/or CBD use is an important component of their
lives,†says Lisa Cini, senior living expert and author of BOOM: The Baby Boomers Guide to Leveraging Technology, so that you can Preserve Your Independent Lifestyle & Thrive. “Don’t
forget that much of the boomer generation grew up smoking weed. Some
never stopped, resumed in retirement, or when they were no longer
raising children. Because the aging process is unforgiving as it relates
to pain, seniors are finding relief from achy bones and joints,
arthritis, sleeplessness, and many other ailments, proving that there’s a
great deal more to marijuana than just getting high, especially for
those battling health and comfort challenges.â€
Seniors are using weed in any number of ways, from smoking to baking
and preparing full meals with cannabutter for many perceived health
benefits including relief from insomnia, anxiety, chronic pain,
depression, muscle tension, arthritis, and migraines in addition to
getting high.
For those who desire CBD without THC, popular brands like vitafusion™
now offer gummy vitamins with full spectrum hemp extract and natural
phytocannabinoids (225mg & 10mg CBD per gummy), Blissful Sleep with
5mg Melatonin (300mg with 10mg CBD per gummy) to induce sleep, and
Chillaxed Mood with natural phytocannabinoids & 10mg L-Theanine (300
mg & 10mg CBD per gummy) to promote calm mental alertness, in
contrast to the restless energy sometimes produced by caffeine. CBD
creams and other skin care products are touted for anti-aging and appeal
to boomers. CBD Anti-Aging Cream with Apple Stem Cells, was voted #1
Best Anti-Aging CBD Skin Cream in 2019 and for those with sensitive
skin, Abinoid Botanicals Face Serum – Blue Chamomile & Hemp was
voted #2 best hemp cream.
“Marijuana and CBD use is a reality that can no longer be ignored, as
it’s very much a part of the daily lives of so many,†adds Cini. “It’s
time to mainstream senior-friendly tools for using marijuana, and
consider implications for designing seniors’ living spaces, or help
those marijuana-using seniors living in multi-generational homes to
partake in designated ways and areas as not to offend family members who
don’t use, including children and grandchildren.â€
Posted by AGORACOM-JC
at 4:43 PM on Monday, March 16th, 2020
SPONSOR: BetterU Education Corp.
aims to provide access to quality education from around the world. The
company plans to bridge the prevailing gap in the education and job
industry and enhance the lives of its prospective learners by developing
an integrated ecosystem. Click here for more information.
Can coronavirus do for edtech what demonetisation did for digital payments in India?
The Covid-19 pandemic has forced several schools and colleges across India to temporarily close. In Delhi alone, over two million kids are being forced to stay at home with primary schools shut until March 31.
With fresh cases being reported each day, there are expectations that more schools and colleges will be closed in the coming weeks.
On Nov. 8, 2016, digital payments companies became mainstream in India overnight
after the government suddenly decided to demonetise two high-value
currency notes. Now, education technology (edtech) firms are hoping for
an encore in the wake of the coronavirus outbreak.
The Covid-19 pandemic has forced several schools and colleges across India to temporarily close. In Delhi alone, over two million kids
are being forced to stay at home with primary schools shut until March
31. With fresh cases being reported each day, there are expectations
that more schools and colleges will be closed in the coming weeks.
Edtech companies are jumping to make the most of the situation,
offering free access to their courses during a time that typically flags
off the exam season.
But overnight success might be hard to come for these platforms, experts said.
“While a smartphone is good enough for browsing, social media, and so
on, for studies, assignments, and projects, it doesn’t suffice,â€
Prateek Shukla, CEO & co-founder Bengaluru-based coding bootcamp
Masai School, told Quartz. “A stable internet and electricity connection
is the biggest challenge.†Power outages are still very frequent across
most Indian cities, especially in smaller towns.
And that is just one of the many hurdles. Companies, though, are going all out to make hay.
Wooing India
On March 11, Bengaluru-based Byju’s, the world’s biggest edtech firm,
said it was making all its learning programmes for students in classes 1
through 12 free until April-end. Soon after, rival Toppr offered free
access to its live and video classes for school kids until March 31, and
Unacademy announced 20,000 free live classes for candidates looking to
prep for entrance exams for union public service commission, banking,
railways, and more.
“We want learners to utilise this time…We will support the education
system in every way possible to weather the storm,†said Gaurav Munjal,
co-founder and CEO of Unacademy. Toppr said it will consider extending
the free access for students if schools don’t reopen after March.
Edtech is already well equipped to handle a possible surge in demand,
said Akash Singhal, founder & CEO of edtech startup Illumnus.
Teachers producing online lessons have already been working remotely, so
there is no additional cost in producing lessons.
The initiatives are already bringing in gains.
Noida-based Gradeup has seen a 25% uptick in daily enrolments since
it doubled the number of free video on its platform in light of the
coronavirus outbreak.
During a normal flu season, frequent weed smokers know the drill.
Pay closer attention to everyone’s cough patterns during a smoke
sesh. Stop accepting mouth-wet blunts from strangers. And if you think
you’re coming down with something, wave a lighter under the mouthpiece
before passing the pipe.
This year, obviously, things are a bit more serious. We’re dealing
with multiple citywide quarantines, global economic disruption, and a
pandemic being compared to the damn Spanish flu. It’s enough to make
self-respecting cannabis enthusiasts re-evaluate their medicine cabinet
and diversify their stash box.
Obviously, there’s no dependable research on CBD’s or THC’s effect on
COVID-19. But we do know a few things about cannabis and general
wellness. Down the rabbit hole of alternative cannabinoids and
non-psychoactive cannabis, there is a wealth of potential medicinal
benefits both preventative and curative.
At least when it comes to the regular flu, CBD has been found to help
support immune systems, ease symptoms, and replace over-the-counter
pain relievers, sleep aids, and medicated salves currently taking up
space in our medicine cabinet. But not just any CBD will do, and CBD
alone won’t do it all.
Obviously, the best course of action right now is to keep vigorously
washing your hands, mind your coughs, avoid large crowds, and be a bit
more stingy with your pipes and joints. But if you find yourself
slipping under the weather, for whatever reason, here are a few things
to know about how cannabis might help ease symptoms.
CBD for Immune System Support
Tons more research is required to accurately map the relationship
between the immune and endocannabinoid systems, but it’s well
established that CBD helps reduce self-harming autoimmune and
inflammatory responses. “CBD has been found to act as an immune system
modulator,” says Anna Symonds, director of East Fork Cultivars’ CBD
Certified program. “This means that it’s like a thermostat—it can turn
the level of activity down or up, depending on the body’s needs.”
Tags: CSE, Hemp, Marijuana, small cap, small cap stocks, stocks Posted in Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca – #Cannabis Won’t Cure #Coronavirus, but It Can Help Ease Certain Flu Symptoms $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca
Posted by AGORACOM-JC
at 6:12 PM on Thursday, March 12th, 2020
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
Coronavirus Scare Gives Telehealth an Opening to Redefine Healthcare
With the coronavirus threatening to become a pandemic, health
systems and telehealth vendors see this as an opportunity to bring
connected health to the forefront – and reshape the future of
healthcare.
Most see the exercise as an extension of their preparations for flu
season. Some see this as an opportunity to lobby for telehealth adoption
across the board, saying a possible epidemic offers ample evidence of
the value of telehealth and mHealth.
Defining Telehealth’s Value in a Changing Landscape
“COVID-19 is different because we do not know all the factors
surrounding transmission and its effects on patients,†Jason Hallock,
Chief Medical Officer for SOC Telemed, points out. “Because coronavirus
is new and there have been a significant number of deaths, the
uncertainty surrounding that is scaring both patients and the general
public. Our healthcare workers do not have all the answers
yet. Telehealth providers are challenged to make recommendations when
there are still many unknowns. Telemedicine can be useful to evaluate
and reassure patients in alternative settings, and also can be used to
help patients decide who needs to be seen in the hospital or an
alternative setting like an urgent care.â€
Hallock says telehealth can help by enabling healthcare providers to
treat isolated patients, thus preventing the spread of what has so far
been an extremely contagious virus.
In a Q&A with mHealthIntelligence, Peter Antall, MD,
President and Chief Medical Officer for American Well, offered an
in-depth take on how telehealth might be used.
Q. Telehealth has long been seen as an ideal means of
expediting care during flu outbreaks. How is the coronavirus scare
different? Does this pose any unique challenges that telehealth can
address?
A. The novel coronavirus, or COVID-19, is similar to
influenza in how it is transmitted (airborne), how symptoms manifest
themselves, and the fear it stirs among those individuals at risk. When
evaluating patients through telehealth, we use similar methodology as
that used for influenza, except that the current Centers for Disease
Control and Prevention (CDC) recommendations call for risk
stratification based on known exposure or travel to endemic areas and
referral for testing for those at high risk or those who are sick enough
to need hospital care. Also, unlike with influenza, there are no
current specific treatments, like antivirals, for the coronavirus at
this time.
If local person-to-person spread expands to wide community spread, we
expect care will need to evolve to a method that is quite similar to
how we treat influenza today. Under those circumstances, we will likely
begin diagnosing coronavirus-like illness (CLI) on a clinical basis,
without testing. We would likely then only be expected to refer
inpatients with CLI who need hospital care clinically, while those with
milder symptoms will likely be treated and monitored at home so as to
limit the spread of this disease and not overwhelm our healthcare
facilities.
In this way, telehealth is an ideal venue for an outbreak like this.
We can increase access to care. We can offer care that is commensurate
with the acuity and nature of the symptoms and make referrals as needed.
This helps with infection prevention and control and also allows
patients to receive their care in the home without exposing themselves
to further illness.
One other notable point is the potential for telehealth to help in
providing routine care for other conditions and offset coronavirus fears
in the . Patients have other healthcare needs unrelated to coronavirus,
but many are afraid to go to healthcare settings for fear of catching
disease. This has begun to result in a migration of patients to
telehealth. For example, on February 25, we saw telehealth urgent care
patient volume that was 11 percent higher than expected. Many patients
are now sharing anecdotes indicating they were afraid to sit in a
waiting room, so they used telehealth instead.
Q. Are there new tools or technologies available that can be useful in dealing with the coronavirus?
A. Telehealth itself is a tool in this fight. Keep
in mind that there are many varieties of telehealth. It can be used to
connect a doctor or other provider with a patient in the home via
smartphones or tablets. It can also be used for provider
(specialist)-to-provider consultations in remote areas, for example.
Telehealth carts also exist in healthcare settings and can be used not
only to import care, but also to limit healthcare workers’ exposure to
the virus by using a cart in the isolation room. We see patients
primarily through live video interactions, but we also can fall back to
informed telephone calls, synchronous chatting for therapy and
asynchronous secure messaging for ongoing communications.
The use of symptom trackers and chatbots is another promising area
for coronavirus response. These technologies allow algorithms to be
created and adjusted as more is learned about the coronavirus. These
bots interact with patients and can perform assessments, triage and
ongoing support. The bots can even escalate an interaction to a
telehealth encounter or refer the patient for in-person care.
Finally, home monitoring and medical tricorders are another promising
approach to care. Traditional remote patient monitoring has established
value for managing certain chronic conditions, but the next wave of
home monitoring includes consumer devices like smartwatches (like
the Apple Heart Study), home TVs, and home medical tricorders
like Tytocare that can perform a remote examination. These tools aid
clinicians and patients and provide more robust health data conveniently
from the home setting. Providers can also use the data generated to
better care for the patient or regularly monitor certain conditions.
Q. What must care providers know about telehealth before using it to deal with the coronavirus?
A. Providers must know and understand their role in
this or any other healthcare crisis. They should be well informed and
trained to follow current CDC or World Health Organization guidelines.
They should also understand that telehealth is a powerful tool for
helping fight this outbreak. And they should know that telehealth is a
safe way to treat and/or triage these patients. Whether the provider is a
primary telehealth provider or is not using telehealth today, there is a
real opportunity to participate and play a role in the response.
Providers who have a brick-and-mortar practice should be encouraged
to use telehealth as a triage tool. Providers also need to understand
that during this time, patients with other non-respiratory conditions
also need care. These patients should be afforded a safe way to access
care without risk of infection. Telehealth is also a tool to aid in this
process, as some patients are fearful of going to healthcare facilities
right now. The office-based provider can likewise process other
patients by practicing this way.
Q. What are the barriers or challenges associated with using telehealth to deal with the coronavirus scare?
A. Telehealth visits are typically sufficient to
complete a robust initial assessment. This allow the provider to assign a
risk category, make other diagnoses, or deem the patient as “worried
well.†Some patients may require additional care, as most telehealth in
the home lacks certain medical peripherals that might be needed. Other
reasons for referral would include a high-risk patient who needs to be
tested or a patient who requires escalation of care due to the severity
of their illness. Telehealth visits are generally sufficient for
screening patients, assigning a risk category, answering questions and
recommending the next steps a patient should take.
The barriers to telehealth—such as instances when the patient and
provider do not yet have a relationship—are easily overcome providers
receive similar training around the use of telehealth and as
longitudinal patient records become more available to guide care.
Occasionally the lack of medical peripherals or the inability to touch
the patient during an exam is a barrier, as some patients need hands on
care (e.g., IV, procedures). We have policies that mitigate these
problems in most cases. However, on occasion, a telehealth patient must
be referred for in-person evaluation.
Q. Is there anything that the CDC or any other government
agency can do to support telehealth adoption to deal with the
coronavirus?
A. It is useful for the CDC (and the WHO) to
highlight the important role of telehealth in this outbreak because it
certifies our role within the broader medical community and raises
awareness about this tool.
It would be helpful if the CDC were to make specific recommendations
to telehealth providers that relate to telehealth evaluation of the
coronavirus and associated referrals, coding and monitoring. It would
also be helpful if the CDC were to play a role in advocacy efforts
focused on government reimbursement, particularly in this emergency
situation. Efforts to increase consumer awareness about telehealth as a
safe option for care also could prove essential. When this outbreak
settles down, we would encourage the CDC and HHS to collaborate around
coronavirus standards of care and preparedness so that patients can
expect telehealth providers to be ideally prepared and well-coordinated
for the next outbreak and so that we can offer high-quality care in this
manner to all Americans.
We also believe that our public health system would benefit greatly
from owning its own telehealth network infrastructure. This would allow
the CDC to better scale up, solve for geography and improve
surveillance. It would even allow its public health workers to use
technology to monitor patients under quarantine in the home, saving
themselves travel and limiting healthcare workers’ exposure.
Q. What more can be done with telehealth in the future to
plan for these types of outbreaks, or to perhaps address them before
they become serious?
A. Much needs to be done throughout our country to
better prepare. We need permanent leaders placed at the U.S. Department
of Health and Human Services, the National Institutes for Health, the US
Department of Homeland Security and other key areas, and we need to
reinstate a pandemic-preparedness role at the National Security Council.
We need to fund international efforts to improve screening and research
for emerging diseases, and we need surveillance programs and good
international coordination. We need to fund (not decrease funding) for
our frontline groups, like the CDC, HHS and local public health
services. These are our fighters, and we need them ready and funded
properly as an outbreak like this is a national security issue. We need
stockpiles of materials. Finally, we should be partnering with the
pharmaceutical industry on affordable medications and vaccine research.
Our national telehealth operation today acts like an emergency alert
system. We see cases or potential cases before they are reported. At
American Well, our influenza activity indicator map is more accurate and
more timely than that of the CDC. We already play a meaningful role in
many disease states, including outbreaks. There are still many adoption
and awareness challenges that exist when it comes to telehealth.
Hopefully this unfortunate event will help consumers, providers and
others start to more clearly see how they can and should use telehealth
for future healthcare needs.
Another barrier that we continue to work on is that of reimbursement.
Telehealth is a cost-effective way of receiving care, but it is still
not always a covered benefit by insurance. Most commercial plans are
reimbursing and there is increasing adoption in Medicare Advantage and
Medicaid managed care. But there are still gaps, including a big gap in
fee-for-service coverage for Medicare coverage in the home. Efforts at
reform are underway (see the CONNECT Act), but more work needs to be done so that all Americans can take advantage of this amazing service.
Additionally, with coordination being so important during outbreaks
like this, the simple step of integrating telehealth with other health
information systems, such as EHRs or clinical-decision support, can make
care more seamless and foster better care coordination. This would
speed up access to critical care. Case in point: Consider a scenario
where a patient consults with a physician over a telehealth network and
displays symptoms of COVID-19 while presenting one or more correlating
risk factors. The physician could easily document the experience,
dispatch an alert to a local ED, and ensure precautions are taken by
medical staff to usher this patient into a contained room or unit to
begin testing and treatment. We’re working to ensure this type of
communication is happening at all levels, but there’s still much room
for improvement on this front.
Health System Execs Respond to the Threat
In an op-ed prepared for the Alliance for Connected Care, Todd J.
Vento, MD, MPH, Intermountain Healthcare’s Medical Director of
Infectious Diseases Telehealth Service; Ethan Booker, MD, Medical
Director of MedStar’s Telehealth Innovation Center; and Lawrence “Rustyâ€
Hofmann, MD, Stanford Health’s Medical Director of Digital Health, made
their pitch for telehealth:
“Telehealth, which has proven to be a very useful tool in
addressing patient needs during flu season, will improve our collective
ability to address COVID-19 if it hits on a larger scale. Telehealth offers several advantages over in-person care in the event of a pandemic.
One key advantage of telehealth is speed,†the three wrote.
“Patients can access clinicians 24/7 without an appointment or physical
trip to the doctor. Using telehealth, our providers in the Stanford
Primary Care team, MedStar Health and Intermountain Healthcare have been
actively evaluating and treating patients with influenza. Current
providers at Stanford Health estimate that almost 50% of patients are
getting oseltamivir (Tamiflu). Because there is no current,
specific medication for Coronavirus, we must be able to advise patients
of reasonable self-directed treatment and surveillance to keep them
home.
Keeping patients at home is a significant advantage of
telehealth. In-home video visits limit community exposure by allowing
patients to avoid contact with other patients in waiting rooms and
direct contact with providers during the exam. Our health systems have
providers who are equipped to work from their own homes, significantly
increasing the safety of providers and bolstering the workforce to
respond to crisis. Workforce readiness in a crisis that may include
such dramatic measures as school and day care closures is a significant
concern for health systems which may be strained to respond. Health
systems are also using telehealth to continue surveillance of patients
already identified as at risk while keeping them at home.
Next, telehealth ensures that treatment in brick-and-mortar
settings is reserved for high-need patients. Moreover, with patients
being seen in their own homes, providers and health systems will be able
to triage and screen exponentially more patients with telehealth vs. an
in-person visit.
Finally, telehealth allows patients who do not have access to
infectious diseases (ID) specialists to access this specialized care
from the small number of experts across the country. When Intermountain
first offered ID telehealth consultation to rural systems throughout the
west, one provider fielded 1,000 consultation requests in the first
fifteen months. To date, the service has provided telehealth care to
over 4,700 patients, 50 percent of whom are over 65 years old.
Each of these advantages illustrate how telehealth can thwart the
spread of COVID-19 and stop it from overwhelming our already stretched
medical system.â€
The three health executive also urged lawmakers to take action to reduce barriers to telehealth that have kept adoption low:
“Congress must act to ensure that seniors – a particularly
vulnerable population generally and for this virus in particular – are
able to receive necessary triage and care through telehealth.
Today, there are restrictions in Medicare that prevent providers
outside of very rural areas from being paid for care provided through
telehealth. As a result, many providers do not offer telehealth services
to seniors. The lack of reimbursement creates a perverse incentive of
encouraging patients to come for in-person care, which will only
overwhelm our health system as well as augment the virus’s spread.
Congress must give the Secretary of Health and Human Services the
ability to waive these restrictions in times of public health
emergencies. As part of the bipartisan, bicameral CONNECT for Health
Act, telehealth champions in Congress foresaw this need and drafted a
provision that would give the Secretary the ability to waive telehealth
restrictions just as he/she would waive Conditions of Participation,
Stark Laws licensure, or other requirements when public health
emergencies are declared.â€
Posted by AGORACOM-JC
at 5:12 PM on Thursday, March 12th, 2020
SPONSOR: BetterU Education Corp.
aims to provide access to quality education from around the world. The
company plans to bridge the prevailing gap in the education and job
industry and enhance the lives of its prospective learners by developing
an integrated ecosystem. Click here for more information.
Edtech firms offer free access to colleges that is impacted by Coronavirus
Beginning Thursday, online learning giant Coursera said it is going
to provide every impacted university in the world free access to its
course catalogue through ‘Coursera for Campus’ until July 31
Beginning Thursday, online learning giant Coursera said it is going to provide every impacted university in the world free access to its course catalogue through ‘Coursera for Campus’ until July 31.
Online education companies in India and globally are offering their paid programmmes to students — whether in school or pursuing higher education — free of cost because of the COVID-19 pandemic.
Beginning Thursday, online learning giant Coursera said it is going to provide every impacted university in the world free access to its course catalogue through ‘Coursera for Campus’ until July 31.
“We’re going to make ‘Coursera for
Campus’ offering freely available to any college or university in the
world that is impacted by coronavirus, in the hope that they can rapidly
allow students to start learning and ensure we have minimal impact from
coronavirus on the student community,†said Leah Belsky, chief enterprise officer and senior vice-president, Coursera.
Coursera, founded by Stanford Professors Andrew Ng and Daphne Koller,
has 48 million registered learners worldwide and offers courses,
specialisations, degrees, and certificate programmes online.
The ‘Coursera for Campus’ offers job-relevant online education to
students, alumni, faculty, and employees of firms like Mindtree, Tata
Communications, Axis Bank, Infosys, Airtel, and Manipal Group.
Indian universities can continue teaching their students online
without creating new infrastructure. Coursera’s existing ‘Coursera for
Campus’ partners include Manipal Academy of Higher Education, UPES, Shiv
Nadar University, KL University, NMIMS, and Pearl Academy.
In India, it has 5 million registered learners, and is adding over 100,000 learners per month.
Universities can sign up to provide their enrolled students with
access to more than 3,800 courses and 400 specialisations from
Coursera’s top university and industry partners.
Similarly, Indian education technology firms are also offering free
classes and course material for students impacted by the novel coronavirus. On Wednesday, the World Health Organization declared COVID-19 a global pandemic.
Edtech firm Byju’s also said it will provide free access to its complete app to school students till the end of April.
Some Indian states like Kerala, Karnataka and New Delhi have already announced the closure of schools.
A UNESCO report
states that the education of over 290 million students across 13
countries will be interrupted because of the COVID-19 pandemic.
Another edtech platform Unacademy said it will conduct close to
20,000 free live classes on its platform, across exam categories like
UPSC, banking, railways and so on.
Unacademy claims it has 10,000 educators, 13 million learners, and subscriptions for over 30 exam categories.
Educational Initiatives, a 20-year old edtech company based out of
Bengaluru is also offering 60 days free access of Mindspark to all
students, so that the school closure due to COVID-19 does not impact
their learning.
Mindspark is an artificial intelligence-powered specialised mathematics programme developed for children’s learning.
Similarly, edtech firm Toppr is going to provide free live classes to students in classes 5 to 12.
While it is yet to be seen how effective these measures will be,
Coursera’s Belsky said the US education system invested in digitising
after events like Hurricane Katrina, which forced school and college
students to miss studies for months.
According to some estimates, in New Orleans alone, 110 of the 126
public schools were completely destroyed and students had to be moved to
neighbouring states to complete their education.
Posted by AGORACOM-JC
at 4:20 PM on Wednesday, March 11th, 2020
SPONSOR: BetterU Education Corp.
aims to provide access to quality education from around the world. The
company plans to bridge the prevailing gap in the education and job
industry and enhance the lives of its prospective learners by developing
an integrated ecosystem. Click here for more information.
Digital Learning: Can it Solve the Access to Education Problem for Indian Students?
India is home to the largest youth population in the world.
As per recent government statistics, we have an estimated 430 million people under the age of 18.
Digital learning can help tackle existing problems in the education sector such as shortage of skilled teachers, lack of adequate teaching materials and so on.
India is home to the largest youth population in the world. As per
recent government statistics, we have an estimated 430 million people
under the age of 18. These young minds hold immense potential to build a
strong future for themselves and the country. A potential that is often
held to ransom by an education system marred by outmoded methods of
teaching, disproportionate student to teacher ratio, a shortage of
skilled teachers and lack of adequate teaching materials.
At a time when technology is transforming every
other aspect of our existence, it is only natural that we turn to tech
tools to disrupt the way we learn. A lack of access and resources
emerges as a constant stumbling block in our youth’s pursuit of
education – a problem that can be tackled by modernising the education
system through digital learning. Here’s how:
Education beyond Boundaries
Digital content and e-learning can bring entire
teaching modules to your doorstep through smart devices, making it
possible for students to continue working toward completing their
education even if they jump off the path of traditional learning. With a
boom in cheaper data and devices, this mode of learning proves
especially effective in pursuit of higher education or
career-oriented skills. Access to online learning opportunities through
remote classes, webinars and online academies can accord equal learning
opportunities to students in Tier II and III cities as well as rural
areas where skilled educators in one’s desired field of study may not be
available.
Personalised Learning
The advent of deep data analytics, Artificial Intelligence and
Machine Learning, personalised learning has become a tangible reality.
These tech tools allow enable an identification of student goals –
whether it is securing merit, landing jobs or simply amassing knowledge –
and create educational content to suit these goals. This promotes a
truly personalised approach toward learning. With the inclusion of edtech
networks and multimedia in education, learning and teaching methods
have evolved greatly in their methodology, style and content.
Learning on the Go
Gadgets are an integral part of the youth’s lifestyle today. From
shopping to entertainment and social interactions, they seek everything
on their finger tips and on the go. Their approach toward education and
learning is no exception to this tendency. Digital learning allows them
to consume educational content in a format they’re more comfortable in
and at a place and setting of their choosing.
Affordability
The cost of higher education in India is steep. By
comparison, specialised online course are far more affordable. If you
factor in the costs of moving to and living in a big city for students
from Tier II and III cities, small towns and rural areas, professional
online courses don’t cost a fraction of brick-and-mortar set ups. It is
for this reason that India is fast emerging as the second biggest market
for MOOCs or open online courses, after the US. This new educational
revolution presents great opportunity to help the youth access
high-quality education and training, at affordable price points, from
the comfort of their homes.
Job Readiness
The higher education in India essentially revolves around securing a
stable – ideally, well-paying – job. With easy access to e-learning
platforms and digital content, students can access the right kind of
content in a format fit for their preferred mode of consumption and be
better equipped to meet this goal. For instance, the same curriculum can
be easily tweaked to suit academic and competitive purposes in a
cost-effective manner in the e-book format.
Future-Ready Education
The world around us is changing at a lightning fast pace, thanks to the constant eruptions of the technology front.
Sadly, most of the traditional forums of learning – be it schools,
colleges or universities – find themselves lagging behind when it comes
to tailoring the course content as per the changing demands of the times
we live in. Besides, overhauling entire course curriculums can often a
slow, time-consuming process. In such a scenario, professionally
tailored online courses can be a bankable alternative in amassing skills
training that contributes to employability and is in line with the
learners’ interests.
It is undisputable that the future of education will be defined by digital content
and learning. Students in India can ride this wave to tide over the
inherent flaws in our education system and set themselves up for success
in their chosen profession.
Tags: online education, small cap stocks, tsx Posted in betterU Education Corp | Comments Off on Digital Learning #Edtech: Can it Solve the Access to Education Problem for Indian Students? – SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca
Posted by AGORACOM-JC
at 1:15 PM on Monday, March 9th, 2020
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
Healthcare IT Market Worth $511.06 Billion by 2027
Healthcare IT market is expected to grow at a CAGR of 13.8% from 2019 to reach $511.06 billion by 2027.
London, March 06, 2020 – According to a new market research report “Healthcare IT Market
by Product (EMR, mHealth, PHM, RIS, PACS, RCM, Healthcare Analytics,
Telehealth, SCM, HIE), Component (Software, Service), Delivery Mode
(Web, Cloud) and End User (Hospital, Payer, Pharmacy, Ambulatory,
Homecare)- Global Forecast to 2027â€, published by Meticulous
Research®, the healthcare IT market is expected to grow at a CAGR of
13.8% from 2019 to reach $511.06 billion by 2027.
Health Information Technology (Healthcare IT) is a broad term that
defines the technology and infrastructure utilized to record, analyze,
and share patient health data in healthcare organizations. The aim of
Healthcare IT solutions is to offer better care for patients and help
accomplish health equity. It also endorses recording of patient data to
improve healthcare delivery and allow for analysis of information for
both healthcare practitioners and ministry of health/government
agencies.
With increasing pressure to curtail healthcare cost and improve
healthcare quality, investments in healthcare IT are gaining traction
and are largely driven by the need for savings, economies of scale, and
improving cash flow. According to a survey performed by Octopus group,
more than 100 global institutional investors have planned to increase
their investment in healthcare infrastructure, including health IT, by
$200 billion over the next five years. By adopting various healthcare IT
solutions such as EHR, PACS, and CPOE among others, healthcare
organizations have reduced the operational cost and improved savings
along with better patient care. For instance, with increasing adoption
of Cerner Dynamic Documentation platform, Northern Light Health (U.S.)
saved an estimated $1.3 million annually, by increasing provider
efficiency, improving satisfaction with their electronic health record,
and streamlining the discharge process. Similarly, by adopting Cerner
ITWorks, University of Missouri Health Care (U.S.) reduced the
organization’s IV obsolescence rate by more than 43% over three months.
In addition, the university also adopted Cerner’s revenue cycle
management solutions in 2018.
The healthcare IT solutions market study presents historical market
data in terms of value (2017, and 2018), estimated current data (2019),
and forecasts for 2027 – by product, component, delivery mode, end-user,
and geography. The study also evaluates industry competitors and
analyzes their market share at the global and regional level.
Based on product type, the healthcare providers solutions segment
accounted for the largest share of the healthcare IT market and is
slated to grow faster during the forecast period. The large share of
this segment is primarily attributed to the factors such as growing
focus on patient safety & care, increasing demand for integrated
healthcare solutions, rising investments in development of healthcare
infrastructure in emerging countries, increasing number of government
initiatives & regulatory mandates on implementing eHealth solutions,
increasing demand for quality healthcare, and rising awareness about
electronic health records (EHRs). In addition, growing geriatric
population & related ailments and patient workload on healthcare
systems across the globe are also driving adoption of digitization
solutions among healthcare providers.
Based on component type, the services segment held the largest share
of the overall healthcare IT market. The largest share of this segment
is mainly attributed to the increasing need to reduce healthcare costs,
shift towards cloud-based services, rising adoption of digital solutions
across healthcare organizations, and growing need to reduce
administrative overheads of the healthcare industry.
Based on delivery mode, the overall healthcare IT market is segmented
into web/cloud based and on-premises. Web & cloud-based solutions
accounted for the largest share of the overall healthcare IT solutions
market owing to its benefits such as on lower upfront cost, on-demand
self-serving deployment model, excessive storage flexibility, and
greater security.
Based on the end user, healthcare providers held the largest share of
the overall healthcare IT market and is projected to grow at a fastest
CAGR during the forecast period. The largest share of this segment is
mainly attributed to rising patient volume, growing awareness about
electronic health records (EHRs), growing healthcare spending by the
countries across globe, and increasing adoption of healthcare IT
solutions by healthcare providers.
The report also includes extensive assessment of the product
portfolio, geographic analysis, and key strategic developments adopted
by leading market participants in the industry over the past 4 years
(2016–2019). The healthcare IT solutions market has witnessed number of
new product launches, agreements, partnerships & collaborations,
expansions, and acquisitions in the recent years. For instance, in
October 2019, Cerner collaborated with ResMed (U.S.) to help providers
make more informed treatment decisions, control costs, and deliver
seamless care across health systems. Similarly, in July 2019, McKesson
opened its new distribution center in Puyallup, Washington, U.S. to
serve hospitals, health systems, community pharmacies, and national
retail pharmacies across the state of Washington.
The key players operating in the global healthcare IT market are
McKesson Corporation (U.S.), Optum Health (U.S.), International Business
Machine Corporation (IBM) (U.S.), Allscripts Healthcare Solutions, Inc.
(U.S.), athenahealth, Inc. (U.S.), Epic Systems Corporation (U.S.),
Dell Technologies Inc. (U.S.), GE Healthcare (U.S.), Cerner Corporation
(U.S.), Oracle Corporation (U.S.), Cognizant Technology Solutions
Corporation (U.S.), Nuance Communications, Inc. (U.S.), eClinicalWorks
(U.S.) NextGen Healthcare, Inc. (U.S.), Computer Programs and Systems,
Inc. (CPSI) (U.S.), Conifer Health Solutions, LLC. (U.S.), 3M Company
(U.S.), Koninklijke Philips N.V. (The Netherlands), and Infor, Inc.
(U.S.) among others.
Tags: EKG, mhealth, small cap stocks, stocks Posted in CardioComm Solutions | Comments Off on Healthcare IT #Mhealth Market Worth $511.06 Billion by 2027 SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca
Posted by AGORACOM-JC
at 12:14 PM on Thursday, March 5th, 2020
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
DEA Proposes New Mhealth Rule for Substance Abuse Treatment
A proposed rule change would allow providers to use mHealth tools
more freely in substance abuse treatment programs, but it isn’t the rule
that telehealth advocates have been anticipating.
March 04, 2020 – Federal officials have proposed easing restrictions
on the use of mHealth in substance abuse programs – but the changes
aren’t what everyone has been expecting.
“The NTP registrants that operate or wish to operate mobile
components (in the state that the registrant is registered in) to
dispense narcotic drugs in schedules II-V at a remote location for the
purpose of maintenance or detoxification treatment would not be required
to obtain a separate registration for a mobile component,†a summary of
the rule states.
“This proposed rule would waive the requirement of a separate
registration at each principal place of business or professional
practice where controlled substances are dispensed for those NTPs with
mobile components that fully comply with the requirements of the
proposed rule, once finalized,†the summary continues. “These revisions
to the regulations are intended to make maintenance or detoxification
treatments more widely available, while ensuring that safeguards are in
place to reduce the likelihood of diversion.â€
The notice is different from what telehealth and mHealth providers
have been waiting for: a rule that would ease federal restrictions on
the prescription of scheduled drugs via telemedicine, and one that
federal officials had been expected to unveil. It even prompted Virginia
Sen. Mark Warner to issue a press release congratulating the DEA on
making that move.
“The opioid and addiction epidemic has had a devastating impact on communities in Virginia and across the country,†Warner, who had sent a letter to the DEA in January,
said in a press release that has since been deleted. “We need to use
every tool at our disposal to ensure that individuals struggling with
addiction can access the treatment they need, and telehealth is an
important part of that. I am pleased the DEA has finally issued proposed
rulemaking that will improve telehealth access for these patients and I
hope they will work quickly to finalize this rulemaking once
stakeholders have had an opportunity to weigh in.â€
That deadline passed without action. In November, the Justice Department announced plans to issue a proposed rule to
create that registration process. But nothing has happened since then,
and the DEA and other federal agencies have refused to give any updates.
Last month’s ruling leaves healthcare providers looking for more
leeway in treating substance abuse issues both pleased and disappointed.
It’s a step in the right direction for programs using digital health
tools, but not the leap forward that so many have been anticipating.
Posted by AGORACOM-JC
at 8:24 AM on Thursday, March 5th, 2020
Announced the advancement of its previously announced Joint Venture Partnership with Heritage Cannabis Holdings Corp. (CSE: CANN), based in Sandy, Oregon, USA.
Now advancing the JV with the order and installation of extraction and post-production equipment units at Empower’s existing licenced hemp processing facility in Sandy, Oregon,
Will immediately begin performing hemp-based product manufacturing for proprietary formulations, tolling services, and third-party white labelling services for other distributors throughout the United States
VANCOUVER, BC / March 5, 2020 / EMPOWER CLINICS INC. (CSE:CBDT) (OTC:EPWCF) (Frankfurt 8EC) (“Empower” or the “Company“), a vertically integrated and growth-oriented life sciences company is pleased to announce the advancement of its previously announced Joint Venture Partnership (“JV”) with Heritage Cannabis Holdings Corp. (CSE: CANN) (“Heritage”), based in Sandy, Oregon, USA.
In September 2019, Empower announced it had entered into a Letter of
Intent (“LOI”) to form a 50/50 ownership JV with Heritage for the
extraction of hemp for CBD oil production, and formulated CBD products.
The JV is equally funded by both parties and since formation CDN$250,000
has been provided to the JV.
Heritage and Empower are now advancing the JV with the order and
installation of extraction and post-production equipment units at
Empower’s existing licenced hemp processing facility in Sandy, Oregon,
in order to immediately begin performing hemp-based product
manufacturing for proprietary formulations, tolling services, and
third-party white labelling services for other distributors throughout
the United States.
The proprietary branded products will be distributed through
Empower’s corporately owned physician staffed health clinics in Oregon
and Arizona, online at www.sunvalleyhealth.com and in upcoming new franchise locations, which currently have access to over 165,000 patients.
Additionally, related downstream equipment is now being installed
including gel cap processing, tincture bottle and vape cartridge
filling, as well as labelling, packaging, storage and shipping services,
to offer full-service end-to-end products to third parties.
Heritage is providing training and supervision related to the
proprietary methods of extraction and oil production that is already
being successfully produced in Canada by Heritage.
“Having the backing of an experienced partner with the financial
strength of Heritage Cannabis is proving to be so beneficial for the
development of our first extraction facility”, said Steven McAuley,
Chief Executive Officer of Empower. “Together, we have already
identified numerous opportunities to bring new orders to the JV
facility, ensuring we leverage the capacity we are building.”
“We are very pleased to be advancing our U.S. strategy through this
mutually beneficial partnership with Empower, which provides Heritage
ease of access to the world’s largest cannabis market”, stated Clint
Sharples, Chief Executive Officer of Heritage. “The installation of
extraction units is the next phase of the JV and another step toward
successfully furthering our growth strategies.”
ABOUT EMPOWER
Empower is a vertically-integrated health & wellness brand with
it’s first hemp-derived CBD extraction facility under development, the
Company produces its proprietary line of cannabidiol (CBD) based
products and distributes products through company owned and franchised
clinics, with wholesale partnerships, online channels and with new
retail opportunities nationwide in the U.S. The company is a leading
multi-state operator of a network of physician-staffed wellness clinics,
focused on helping patients improve and protect their health, through
innovative physician recommended treatment options. The company has
commenced activity on how to connect its significant data, to the
potential of the efficacy of alternative treatment options related to
hemp-derived cannabidiol (CBD) therapies.
About Heritage Cannabis Holdings Corp.
The Company is focused on becoming a vertically integrated cannabis
provider that currently has two Health Canada approved licenced
producers, through its subsidiaries Voyage Cannabis Corp. and CannaCure
Corp. both regulated under the Cannabis Act Regulations. Working under
these two licences, Heritage has two additional subsidiaries, Purefarma
Solutions, which provides extraction services, and a Medical Services
Division which is focused on cannabis based medical solutions. Heritage
as the parent company, is focused on providing the resources for its
subsidiaries to advance their products or services to compete both
domestically and internationally.
Investors: Dustin Klein SVP, Business Development [email protected] 720-352-1398
For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain “forward-looking statements”
or “forward-looking information” (collectively “forward looking
statements”) within the meaning of applicable Canadian securities laws.
All statements, other than statements of historical fact, are
forward-looking statements and are based on expectations, estimates and
projections as at the date of this news release.Forward-looking statements
can frequently be identified by words such as “plans”, “continues”,
“expects”, “projects”, “intends”, “believes”, “anticipates”,
“estimates”, “may”, “will”, “potential”, “proposed” and other similar
words, or information that certain events or conditions “may” or “will”
occur. Forward-looking statements in this news release include
statements regarding; the Company’s intention to open a hemp-based CBD
extraction facility, the expected benefits to the Company and its
shareholders as a result of the proposed acquisitions and partnerships;
the effectiveness of the extraction technology; the expected benefits
for Empower’s patient base and customers; the benefits of CBD based
products; the effect of the approval of the Farm Bill; the growth of the
Company’s patient list and that the Company will be positioned to be a
market-leading service provider for complex patient requirements in 2019
and beyond. Such statements are only projections, are based on
assumptions known to management at this time, and are subject to risks
and uncertainties that may cause actual results, performance or
developments to differ materially from those contained in the
forward-looking statements, including; that the Company may not open a
hemp-based CBD extraction facility; that legislative changes may have an
adverse effect on the Company’s business and product development; that
the Company may not be able to obtain adequate financing to pursue its
business plan; general business, economic, competitive, political and
social uncertainties; failure to obtain any necessary approvals in
connection with the proposed acquisitions and partnerships; and other
factors beyond the Company’s control. No assurance can be given that any
of the events anticipated by the forward-looking statements will occur
or, if they do occur, what benefits the Company will obtain from them.
Readers are cautioned not to place undue reliance on the forward-looking
statements in this release, which are qualified in their entirety by
these cautionary statements. The Company is under no obligation, and
expressly disclaims any intention or obligation, to update or revise any
forward-looking statements in this release, whether as a result of new
information, future events or otherwise, except as expressly required by
applicable laws.
Tags: CSE, Hemp, Marijuana, small cap, small cap stocks, stocks Posted in Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca Announces Advancement of Joint Venture with Heritage Cannabis in the United States $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca
Posted by AGORACOM-JC
at 3:04 PM on Wednesday, March 4th, 2020
Further to its previous press release dated November 4th, 2019, Company has completed all torch tests successfully, and has received final payment from RISE Energy Technology Center AB
As a result of this success, PyroGenesis has received numerous requests for proposals from potential clients in the field, and recently signed a small order from a multi-billion-dollar international producer of iron pelletsÂ
MONTREAL, March 04, 2020 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation†or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, announced today that, further to its previous press release dated November 4th, 2019, the Company has completed all torch tests successfully, and has received final payment from RISE Energy Technology Center AB (the “Clientâ€).
This contract, originally announced in January of last year, is for a
900-kW plasma torch system which was won in a competitive bid process.
PyroGenesis’ 900-kW plasma torch is used to replace fossil fuel
burners in the iron ore induration (pelletization) process.
Pelletization is the process in which iron ore is concentrated before
shipment, thus significantly reducing the cost of transportation. In
conventional technology, the process heat is provided by fuel oil or
natural gas burners. The combustion, in the burners, of fossil fuels
results in the production of greenhouse gases, mainly CO2. Plasma
torches, by the fact that they can convert renewable electricity to heat
offer an environmentally attractive alternative to fossil fuel burners.
Following the success of the SAT (Site Acceptance Test) of the
high-power plasma torch at the Client’s facility in Sweden, a series of
additional torch tests were performed at the client’s site. As
announced, these tests have concluded successfully, and discussions are
now taking place for follow on work and additional torch orders.
According to management, a typical pellet plant producing 10 million
metric tonnes of pellets annually emits approximately one million metric
tonnes of CO21. The total world pellet production of 400 million metric
tonnes of pellets represents a potential market for torch sales in
excess of $10B worldwide. The world pellet industry generates about 40
million metric tonnes of CO2 every year. The use of plasma torches
running off a clean electrical grid would reduce these emissions
significantly. For reference, 40 million tonnes of CO2 represent the
combined yearly emissions of 8.7 million US passenger vehicles2.
As a result of this success, PyroGenesis has received numerous
requests for proposals from potential clients in the field, and recently
signed a small order from a multi-billion-dollar international producer
of iron pellets. This order is to model and evaluate the performance
of PyroGenesis’ torch in an existing industrial furnace. If successful,
this would potentially lead to a multi-torch order aimed at replacing
burners in their industrial pelletizing plant. An iron pelletizing
furnace typically uses dozens of high-power burners (typically between
1-5 MW).
“Our success with RISE has demonstrated to the industrial
manufacturing sector that our Plasma Torches represent an opportunity to
significantly cut GHG emissions through a simple bolt-on replacement of
their current fossil fuel burners,†said Mr. P. Peter Pascali,
President and CEO of PyroGenesis. “Given how compelling our torch
offering is, particularly in light of the environmental pressure the
industry is under (only recently a new trend has emerged where financial
institutions are tying credit facilities and debt issuances to carbon
reduction targets for multi-national industrial and mining
conglomerates) we expect the demand for our torches to grow
exponentially.â€
1 M. Huerta, J. Bolen, M. Okrutny, I. Cameron and K. O’Leary,
“Guidelines for Selecting Pellet Plant Technologyâ€, Iron Ore Conference
2015 Proceedings, Perth, WA, July 13-15, 2015
PyroGenesis Canada Inc., a high-tech company, is the world leader in
the design, development, manufacture and commercialization of advanced
plasma processes and products. We provide engineering and manufacturing
expertise, cutting-edge contract research, as well as turnkey process
equipment packages to the defense, metallurgical, mining, advanced
materials (including 3D printing), oil & gas, and environmental
industries. With a team of experienced engineers, scientists and
technicians working out of our Montreal office and our 3,800 m2
manufacturing facility, PyroGenesis maintains its competitive advantage
by remaining at the forefront of technology development and
commercialization. Our core competencies allow PyroGenesis to lead the
way in providing innovative plasma torches, plasma waste processes,
high-temperature metallurgical processes, and engineering services to
the global marketplace. Our operations are ISO 9001:2015 and AS9100D
certified, and have been since 1997. PyroGenesis is a publicly-traded
Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR)
and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com.
This press release contains certain forward-looking statements,
including, without limitation, statements containing the words “may”,
“plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”,
“expect”, “in the process” and other similar expressions which
constitute “forward- looking information” within the meaning of
applicable securities laws. Forward-looking statements reflect the
Corporation’s current expectation and assumptions and are subject to a
number of risks and uncertainties that could cause actual results to
differ materially from those anticipated. These forward-looking
statements involve risks and uncertainties including, but not limited
to, our expectations regarding the acceptance of our products by the
market, our strategy to develop new products and enhance the
capabilities of existing products, our strategy with respect to research
and development, the impact of competitive products and pricing, new
product development, and uncertainties related to the regulatory
approval process. Such statements reflect the current views of the
Corporation with respect to future events and are subject to certain
risks and uncertainties and other risks detailed from time-to-time in
the Corporation’s ongoing filings with the securities regulatory
authorities, which filings can be found at www.sedar.com, or at
www.otcmarkets.com. Actual results, events, and performance may differ
materially. Readers are cautioned not to place undue reliance on these
forward-looking statements. The Corporation undertakes no obligation to
publicly update or revise any forward- looking statements either as a
result of new information, future events or otherwise, except as
required by applicable securities laws. Neither the TSX Venture
Exchange, its Regulation Services Provider (as that term is defined in
the policies of the TSX Venture Exchange) nor the OTCQB accepts
responsibility for the adequacy or accuracy of this press release.
SOURCE PyroGenesis Canada Inc.
For further information please contact:
Rodayna Kafal, Vice President Investors Relations and Strategic Business Development Phone: (514) 937-0002, E-mail: [email protected]
Tags: PyroGenesis, small cap stocks, stocks, tsx Posted in PyroGenesis Canada Inc. | Comments Off on PyroGenesis $PYR.ca Successfully Completes all Torch Tests for RISE Energy Technology Center AB LMT $RTN $NOC $UTX $HPQ.ca $DDD.ca $SSYS $PRLB